A

ALNY

Alnylam Pharmaceuticals Inc

223.95

Aug 12 • 3:59 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Large NASD

Peers: ARGX REGN VRTX BMRN ONC BIIB AMGN GILD ABBV LLY

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP CGGR QQQM

Scroll to Statements

Index	NDX
Market Cap	29.97B
Enterprise Value	29.65B
Income	807.99M
Sales	4.80B
Book/sh	10.13
Cash/sh	24.72
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2500
IPO	May 28, 2004

P/E	37.81
Forward P/E	21.89
PEG	0.29
P/S	6.24
P/B	22.12
P/C	9.06
P/FCF	37.74
EV/EBITDA	28.11
EV/Sales	6.17
Quick Ratio	2.99
Current Ratio	3.05
Debt/Eq	2.21
LT Debt/Eq	1.98
Option/Short	Yes / Yes

EPS (ttm)	5.92
EPS next Y	10.23
EPS next Q	1.79
EPS this Y	188.75%
EPS next Y	52.09%
EPS next 5Y	76.71%
EPS past 3/5Y	- -
Sales past 3/5Y	52.98% 49.77%
EPS Y/Y TTM	347.31%
Sales Y/Y TTM	95.14%
EPS Q/Q	337.86%
Sales Q/Q	66.86%
Earnings	Jul 30 BMO
EPS/Sales Surpr.	-25.78% -2.36%

Insider Own	0.41%
Insider Trans	-9.98%
Inst Own	98.83%
Inst Trans	-0.42%
ROA	15.96%
ROE	100.70%
ROIC	20.01%
Gross Margin	79.65%
Oper. Margin	20.81%
Profit Margin	16.82%
SMA20	-9.19%
SMA50	-18.75%
SMA200	-33.96%
Trades

Shs Outstand	133.73M
Shs Float	133.27M
Short Float	3.60%
Short Ratio	2.99
Short Interest	4.80M
52W High	495.55 -54.81%
52W Low	197.81 13.21%
Volatility	4.73% 4.67%
ATR (14)	13.98
RSI (14)	37.44
Beta	0.29
Rel Volume	0.00
Avg Volume	1.61M
Volume	0

Perf Week	-2.09%
Perf Month	-20.38%
Perf Quarter	-23.31%
Perf Half Y	-30.66%
Perf YTD	-43.68%
Perf Year	-47.91%
Perf 3Y	20.54%
Perf 5Y	11.46%
Perf 10Y	202.31%
Recom	1.58
Target Price	377.84
Prev Close	223.95
Price	223.95
Change %	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)